Aura Biosciences, Inc. (AURA): Price and Financial Metrics

Aura Biosciences, Inc. (AURA): $5.95

0.77 (+14.86%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add AURA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#114 of 301

in industry

AURA Price/Volume Stats

Current price $5.95 52-week high $12.38
Prev. close $5.18 52-week low $4.34
Day low $5.11 Volume 746,500
Day high $6.20 Avg. volume 237,643
50-day MA $6.03 Dividend yield N/A
200-day MA $8.03 Market Cap 298.84M

AURA Stock Price Chart Interactive Chart >


Aura Biosciences, Inc. (AURA) Company Bio


Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.


AURA Latest News Stream


Event/Time News Detail
Loading, please wait...

AURA Latest Social Stream


Loading social stream, please wait...

View Full AURA Social Stream

AURA Price Returns

1-mo N/A
3-mo -22.22%
6-mo -32.00%
1-year -18.16%
3-year -65.04%
5-year N/A
YTD -27.62%
2024 -7.22%
2023 -15.62%
2022 -38.16%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!